Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP636375.RAET6cQr35ZrzF6oJWmdrffLdDwgK4rXZ_30s6uHsRw90130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP636375.RAET6cQr35ZrzF6oJWmdrffLdDwgK4rXZ_30s6uHsRw90130_assertion type Assertion NP636375.RAET6cQr35ZrzF6oJWmdrffLdDwgK4rXZ_30s6uHsRw90130_head.
- NP636375.RAET6cQr35ZrzF6oJWmdrffLdDwgK4rXZ_30s6uHsRw90130_assertion description "[Building on prior work in immune deviation and with PPAR agonists, we have demonstrated that PPARalpha agonists can alter the cytokine phenotype of myelin-reactive T cells, alter their encephalitogenicity, and be useful in the treatment of EAE.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP636375.RAET6cQr35ZrzF6oJWmdrffLdDwgK4rXZ_30s6uHsRw90130_provenance.
- NP636375.RAET6cQr35ZrzF6oJWmdrffLdDwgK4rXZ_30s6uHsRw90130_assertion evidence source_evidence_literature NP636375.RAET6cQr35ZrzF6oJWmdrffLdDwgK4rXZ_30s6uHsRw90130_provenance.
- NP636375.RAET6cQr35ZrzF6oJWmdrffLdDwgK4rXZ_30s6uHsRw90130_assertion SIO_000772 16484546 NP636375.RAET6cQr35ZrzF6oJWmdrffLdDwgK4rXZ_30s6uHsRw90130_provenance.
- NP636375.RAET6cQr35ZrzF6oJWmdrffLdDwgK4rXZ_30s6uHsRw90130_assertion wasDerivedFrom befree-20150227 NP636375.RAET6cQr35ZrzF6oJWmdrffLdDwgK4rXZ_30s6uHsRw90130_provenance.
- NP636375.RAET6cQr35ZrzF6oJWmdrffLdDwgK4rXZ_30s6uHsRw90130_assertion wasGeneratedBy ECO_0000203 NP636375.RAET6cQr35ZrzF6oJWmdrffLdDwgK4rXZ_30s6uHsRw90130_provenance.